What is Neuroscience?
Neuroscience is a branch of science and medicine that focuses on the function of the nervous system and brain at the level of the nerve cells, the glial cells and all other supporting structures including myelin. Investigation tools include quantitative electroencephalogram (qEEG mapping), PET brain scans, nerve conduction studies and MRI brain Neuroquant Volumetrics. These and other investigations inform clinicians about the nature and location of dysfunction or malfunction within the nervous system and brain. It also lets them know whether the malfunctioning is associated with cognitive decline, aberrant behaviour or mood disorders.
Improving cognitive function and treating chronic pain, mood disorders and infection or trauma related brain injuries
Dr Hale has been using neuroscience-based assessment techniques for more than three years now and is continually updating management options to find the safest and most effective methods available to help her patients.
She and Dr Paula Rodrigues will soon be introducing EEG and qEEG brain mapping investigations to further define the nature of nervous system and brain problems associated with complex and chronic illness including cognitive decline (at any age), severe post infectious fatigue, anxiety (either isolated or associated with mould/mycotoxin illness and gut disorders such as SIBO), depression, and cognitive or behavioural problems after traumatic brain injury.
Dr Hale will be using these assessments in combination with MRI brain volumetrics (neuroquant analyses performed by CorTech Labs in California) to upgrade her assessments and management options even further. She is currently collaborating with Dr Mary Ackerly and the University of Arizona to publish the first clinical series of the ‘Triage Atrophy Brain Report’ (a sub-analysis of the neuroquant report from CorTech Labs) in patients with cognitive dysfunction and chronic illness.
Dr Hale and Dr Paula Rodrigues are using evidenced based EMDR trauma release where indicated, LENS neurofeedback, audio-visual entrainment and cranio-electrostimulation (CES) to assist patients with cognitive decline, chronic pain, mood disorders and infection or trauma related brain injury.
They are also breaking new ground in disorders that involve limbic system dysfunction, where the body and brain’s fight or flight responses are stuck in the ‘ON’ position. This may be due to trauma (especially early life trauma), chronic illness, physical trauma and even mycotoxin exposure. They have found that the Neuroscience techniques help the brain lead the way to damp down the body’s ‘fight or flight’ system. The limbic system includes the thalamus, hypothalamus, hippocampus and amygdala. Secondary structures closely linked to the limbic system include the cerebral cortex, the cerebellum, the adrenals, the GUT and other organs and these components can all be involved in either reducing or magnifying the ‘fright and flight’ related illnesses.
Why use neuroscience?
Neuroscience is the science of how the brain is functioning at the level of the nerve cell and all the supporting structures such as myelin and the glial cells. It is also the science of the techniques that assist in the coherent function of a the brain as a whole. Examples include LENS neurofeedback and audio-visual entrainment. Neuroscience techniques also assess and treat trauma-related cognitive and behavioural problems by helping the brain damp down its own ‘fright and flight’ system. The fright and flight system in the brain involves the limbic system which includes the thalamus, hypothalamus, hippocampus and amygdala. The ‘fright and flight’ system also involves the cerebral cortex, the cerebellum, the adrenals, the GUT and other organs and these components can all be involved in either reducing or magnifying the ‘fright and flight’ related illnesses.
Can Neuroscience techniques improve patients with dementia?
It is early days in the research behind neuroscience techniques, but the earlier patients can be assessed, the earlier all their unique underlying contributors can be discovered and addressed. With the almost universal failure of pharmaceutical drug trials in dementia treatment, more and more clinicians and researchers are turning their focus to treatable and preventable contributors to cognitive decline. The broad groups of contributors include VASCULAR disease, ATROPHIC factors (with ageing), INFLAMMATORY (neuroinflammation), GLYCOTOXIC (Type III diabetes), TOXIC (including life-long exposures to neurotoxic heavy metals and other environmental toxins) and TRAUMA – even the most insignificant physical head trauma can set of a silent, chronic yet damaging inflammatory cascade that leads to neurodegeneration.
Dr Bredesen MD (author of ‘The End of Alzheimer’s)
Dr Hale attended one of Dr Bredesen’s earliest workshops at the Buck Institute in California, and since then, has incorporated his recommendations in terms of the investigations and treatment. She hopes to go even further and at the fraction of the cost of Bredesen’s Re-Code protocol, improve patient outcomes using neuroscience technologies including qEEG mapping, audio-visual entrainment and CES techniques. The EARLIER any cognitive decline is detected, assessed and managed, the GREATER the chance of reversing, stopping or slowing patients’ future decline. Success also depends on patients having an effective support team (at least 2-3 family members) and ensuring adherence to brain-health promoting eating plans, targeted supplements, exercise, sleep hygiene and their regular neuroscience technologies.